Hansen Medical Announces 2010 Third Quarter Results Conference Call
22 10월 2010 - 7:10AM
Marketwired
Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible
robotics and the developer of robotic technology for accurate 3D
control of catheter movement, announced today that it will release
its financial and operating results for the third quarter ended
September 30, 2010 after market close on Wednesday, November 3,
2010.
Hansen Medical will host a conference call at 5:00 p.m. ET (2:00
p.m. PT) on November 3, 2010 to discuss its results. The call may
be accessed by dialing 877-941-2321 (480-629-9714 for international
callers) and via the Internet in the Investor Relations section of
Hansen Medical's website at www.hansenmedical.com. Please go to the
website at least 15 minutes early to register, download and install
any necessary audio software. Following the call, a webcast replay
will be available on Hansen Medical's website, and an audio replay
will also be available by calling 877-870-5176 (858-384-5517 for
international callers) and entering the access code 4379093. The
audio replay will be available through November 10, 2010.
About Hansen Medical, Inc. Hansen Medical,
Inc., based in Mountain View, California, develops products and
technology using robotics for the accurate positioning,
manipulation and control of catheters and catheter-based
technologies. The company's Sensei® system and its Sensei X Robotic
Catheter System were cleared by the U.S. Food and Drug
Administration for manipulation and control of certain mapping
catheters in electrophysiology (EP) procedures. The flexible
robotic platform is compatible with fluoroscopy, ultrasound, 3D
surface map and patient electrocardiogram data. The safety and
effectiveness of the Sensei and Sensei X systems for use with
cardiac ablation catheters in the treatment of cardiac arrhythmias,
including atrial fibrillation (AF), have not been established. In
the European Union, the Sensei and the Sensei X systems are cleared
for use during EP procedures, such as guiding catheters in the
treatment of AF. Additional information can be found at
www.hansenmedical.com.
Investor Contacts: Peter Osborne Interim CFO Hansen
Medical 650.404.5800 Matt Clawson Allen & Caron Inc
949.474.4300 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Hansen Medical, Inc. News Articles